Loading articles...
News Update:
March 2026 Special Issue Announcement – Exclusive Publication Discounts: 60% for Editorial Board Members, 40% for Previous Authors, 25% for New Authors | Fast-Track Review (7–10 Days) | E-Certificate of Publication | Special Issue (Minimum 5 Papers) | Inviting Applications for Editorial Board Membership.
WhatsApp
Back to Articles
Computer Science Open Access Peer Reviewed

PLANT-DERIVED ANTI-CANCER AGENTS IN CLINICAL USE


Authors

Ms. THARWAL POOJA NANDKISHOR, Dr. SUNIL KUMAR SHAH, Dr. SHAHAB AHMAD


Abstract

The expanded rate of cancer worldwide has prompted the revelation and advancement of novel remedial operators for the treatment of threat. Plant inferred bioactive mixes are viable wellspring of anticancer treatment and utilized as lead mixes for medication advancement. Plants have a long history of utilization in the treatment of malignancy. Plants have assumed an important job as a wellspring of compelling anticancer specialists and it is huge that over 60% of at present utilized enemy of malignancy operators are gotten from characteristic sources including plants, marine life forms and smaller scale life forms. This review discusses the effect of plant derived compounds on cancer prevention and their further effect on clinical use.


Keywords

Cancer; plants; clinical trial; compounds.

Publication Details

Published In

Volume 1, Issue 12